Affinity Asset Advisors LLC 13D and 13G filings for Vincerx Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:55 pm Sale | 2023-12-31 | 13G | Vincerx Pharma, Inc. VINC | Affinity Asset Advisors LLC | 0 0.000% | -74,639 (Position Closed) | Filing |
| 2023-02-13 4:11 pm Purchase | 2022-12-31 | 13G | Vincerx Pharma, Inc. VINC | Affinity Asset Advisors LLC | 74,639 7.040% | 17,870 (+31.48%) | Filing |
| 2022-02-11 4:13 pm Purchase | 2021-12-31 | 13G | Vincerx Pharma, Inc. VINC | Affinity Asset Advisors LLC | 56,768 5.390% | 2,957 (+5.50%) | Filing |
| 2021-11-22 2:50 pm Purchase | 2021-11-10 | 13G | Vincerx Pharma, Inc. VINC | Affinity Asset Advisors LLC | 53,811 5.120% | 53,811 (New Position) | Filing |